Whan In Pharm Statistics
Total Valuation
Whan In Pharm has a market cap or net worth of KRW 174.20 billion. The enterprise value is 122.03 billion.
Market Cap | 174.20B |
Enterprise Value | 122.03B |
Important Dates
The next estimated earnings date is Friday, May 2, 2025.
Earnings Date | May 2, 2025 |
Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
Whan In Pharm has 15.27 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 15.27M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 28.36% |
Owned by Institutions (%) | 18.72% |
Float | 10.94M |
Valuation Ratios
The trailing PE ratio is 7.45 and the forward PE ratio is 8.62.
PE Ratio | 7.45 |
Forward PE | 8.62 |
PS Ratio | 0.67 |
PB Ratio | 0.46 |
P/TBV Ratio | 0.47 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.82, with an EV/FCF ratio of -18.31.
EV / Earnings | 5.22 |
EV / Sales | 0.47 |
EV / EBITDA | 3.82 |
EV / EBIT | 5.20 |
EV / FCF | -18.31 |
Financial Position
The company has a current ratio of 4.75, with a Debt / Equity ratio of 0.00.
Current Ratio | 4.75 |
Quick Ratio | 3.03 |
Debt / Equity | 0.00 |
Debt / EBITDA | 0.01 |
Debt / FCF | -0.06 |
Interest Coverage | 929.61 |
Financial Efficiency
Return on equity (ROE) is 6.37% and return on invested capital (ROIC) is 3.65%.
Return on Equity (ROE) | 6.37% |
Return on Assets (ROA) | 3.25% |
Return on Invested Capital (ROIC) | 3.65% |
Return on Capital Employed (ROCE) | 5.62% |
Revenue Per Employee | 446.04M |
Profits Per Employee | 40.17M |
Employee Count | 582 |
Asset Turnover | 0.63 |
Inventory Turnover | 2.62 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.01% in the last 52 weeks. The beta is 0.17, so Whan In Pharm's price volatility has been lower than the market average.
Beta (5Y) | 0.17 |
52-Week Price Change | -22.01% |
50-Day Moving Average | 11,636.20 |
200-Day Moving Average | 12,977.05 |
Relative Strength Index (RSI) | 41.45 |
Average Volume (20 Days) | 12,166 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Whan In Pharm had revenue of KRW 259.60 billion and earned 23.38 billion in profits. Earnings per share was 1,531.45.
Revenue | 259.60B |
Gross Profit | 93.66B |
Operating Income | 21.50B |
Pretax Income | 26.95B |
Net Income | 23.38B |
EBITDA | 29.97B |
EBIT | 21.50B |
Earnings Per Share (EPS) | 1,531.45 |
Balance Sheet
The company has 52.58 billion in cash and 413.74 million in debt, giving a net cash position of 52.17 billion or 3,416.99 per share.
Cash & Cash Equivalents | 52.58B |
Total Debt | 413.74M |
Net Cash | 52.17B |
Net Cash Per Share | 3,416.99 |
Equity (Book Value) | 376.00B |
Book Value Per Share | 24,628.27 |
Working Capital | 158.92B |
Cash Flow
In the last 12 months, operating cash flow was 20.69 billion and capital expenditures -27.36 billion, giving a free cash flow of -6.66 billion.
Operating Cash Flow | 20.69B |
Capital Expenditures | -27.36B |
Free Cash Flow | -6.66B |
FCF Per Share | -436.48 |
Margins
Gross margin is 36.08%, with operating and profit margins of 8.28% and 9.01%.
Gross Margin | 36.08% |
Operating Margin | 8.28% |
Pretax Margin | 10.38% |
Profit Margin | 9.01% |
EBITDA Margin | 11.54% |
EBIT Margin | 8.28% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 300.00, which amounts to a dividend yield of 2.63%.
Dividend Per Share | 300.00 |
Dividend Yield | 2.63% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 19.59% |
Buyback Yield | n/a |
Shareholder Yield | 2.63% |
Earnings Yield | 13.42% |
FCF Yield | -3.83% |
Stock Splits
The last stock split was on April 14, 2010. It was a forward split with a ratio of 2.
Last Split Date | Apr 14, 2010 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Whan In Pharm has an Altman Z-Score of 5.03.
Altman Z-Score | 5.03 |
Piotroski F-Score | n/a |